Steven M. Paul - Apr 1, 2022 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Role
Director
Signature
By: /s/ Mary Beth DeLena, Attorney-in-Fact For: Steven M. Paul
Stock symbol
ALNY
Transactions as of
Apr 1, 2022
Transactions value $
-$2,390,421
Form type
4
Date filed
4/5/2022, 04:05 PM
Previous filing
Feb 17, 2022
Next filing
Jun 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALNY Common Stock Options Exercise $170K +15K +1500% $11.33* 16K Apr 1, 2022 Direct F1
transaction ALNY Common Stock Sale -$42K -253 -1.58% $166.04 15.7K Apr 1, 2022 Direct F1, F2
transaction ALNY Common Stock Sale -$836K -4.95K -31.42% $168.95 10.8K Apr 1, 2022 Direct F1, F3
transaction ALNY Common Stock Sale -$827K -4.87K -45.12% $169.71 5.93K Apr 1, 2022 Direct F1, F4
transaction ALNY Common Stock Sale -$211K -1.24K -20.84% $171.16 4.69K Apr 1, 2022 Direct F1, F5
transaction ALNY Common Stock Sale -$247K -1.43K -30.56% $172.10 3.26K Apr 1, 2022 Direct F1, F6
transaction ALNY Common Stock Sale -$111K -642 -19.71% $173.06 2.62K Apr 1, 2022 Direct F1, F7
transaction ALNY Common Stock Sale -$15.7K -90 -3.44% $174.33 2.53K Apr 1, 2022 Direct F1
transaction ALNY Common Stock Sale -$92.8K -526 -20.82% $176.51 2K Apr 1, 2022 Direct F1, F8
transaction ALNY Common Stock Sale -$147K -825 -41.25% $177.58 1.18K Apr 1, 2022 Direct F1, F9
transaction ALNY Common Stock Sale -$31.3K -175 -14.89% $178.60 1K Apr 1, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALNY Non-Qualified Stock Option (right to buy) Options Exercise $0 -15K -100% $0.00* 0 Apr 1, 2022 Common Stock 15K $11.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 29, 2021. The 15,000 options exercised and sold by the reporting person were due to expire on June 21, 2022.
F2 Sale prices ranged from $165.91 to $166.41.
F3 Sale prices ranged from $168.30 to $169.30.
F4 Sale prices ranged from $169.32 to $170.28.
F5 Sale prices ranged from $170.70 to $171.63.
F6 Sale prices ranged from $171.75 to $172.73.
F7 Sale prices ranged from $172.83 to $173.37.
F8 Sale prices ranged from $176.04 to $176.88.
F9 Sale prices ranged from $177.12 to $178.00.